Professor of Medicine, University of Paris-Est. Director of the National Reference Center for Viral Hepatitis B, C &D, and the Department of Virology at the Henri Mondor University Hospital
BIOGRAPHY
Speaker
Event Date & Time
DATE: October 4th, 2017
TIME: 8:00AM PT, 11:00AM ET, 5:00PM (GMT+2)
Abstract
New HCV drugs are now approved which, when used in combination, yield very high rates of cure of HCV infection. The World Health Organization (WHO)'s goal is to eliminate HCV by 2030. This ambitious objective can only be achieved if HCV is screened in people unaware of their infection and when efficient linkage to care strategies are put in place to cure a large proportion of those diagnosed with HCV infection. Virological tools, such as anti-HCV, HCV RNA and HCV core antigen, are of the utmost importance in the patient's care cascade and can be used to optimize linkage to care, in order to achieve the WHO goals by 2030.
After this webinar, you will be able to:
- Discuss the importance of the clinical laboratory in reaching the World Health Organization’s elimination goals
- Understand recent guideline advancements that support Hepatitis C elimination
- Describe simplified diagnostic processes that support improved access to care
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...